Latest GENERAL ATLANTIC LLC Stock Portfolio
GENERAL ATLANTIC LLC Performance:
2025 Q4: 4.56%YTD: 21.73%2024: -9.26%
Performance for 2025 Q4 is 4.56%, and YTD is 21.73%, and 2024 is -9.26%.
About GENERAL ATLANTIC LLC and 13F Hedge Fund Stock Holdings
On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, GENERAL ATLANTIC, L.P. reported an equity portfolio of $2.9 Billions as of 31 Dec, 2025.
The top stock holdings of GENERAL ATLANTIC, L.P. are DLO, , XP. The fund has invested 23% of it's portfolio in DLOCAL and 18.6% of portfolio in CHIME.
The fund managers got completely rid off AKERO THERAPEUTICS (AKRO), ROYALTY PHARMA (RPRX) and ADAGENE (ADAG) stocks. They significantly reduced their stock positions in WEBULL, ALIGNMENT HEALTHCARE (ALHC) and CENTESSA PHARMACEUTICALS (CNTA). GENERAL ATLANTIC, L.P. opened new stock positions in NURIX THERAPEUTICS (NRIX). The fund showed a lot of confidence in some stocks as they added substantially to REVOLUTION MEDICINES (RVMD) and CHIME.
The top stock holdings of GENERAL ATLANTIC, L.P. are DLO, , XP. The fund has invested 23% of it's portfolio in DLOCAL and 18.6% of portfolio in CHIME.
The fund managers got completely rid off AKERO THERAPEUTICS (AKRO), ROYALTY PHARMA (RPRX) and ADAGENE (ADAG) stocks. They significantly reduced their stock positions in WEBULL, ALIGNMENT HEALTHCARE (ALHC) and CENTESSA PHARMACEUTICALS (CNTA). GENERAL ATLANTIC, L.P. opened new stock positions in NURIX THERAPEUTICS (NRIX). The fund showed a lot of confidence in some stocks as they added substantially to REVOLUTION MEDICINES (RVMD) and CHIME.
GENERAL ATLANTIC LLC Annual Return Estimates Vs S&P 500
Our best estimate is that GENERAL ATLANTIC, L.P. made a return of 4.56% in the last quarter. In trailing 12 months, it's portfolio return was 21.73%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| nurix therapeutics | 92,899,100 |
New stocks bought by GENERAL ATLANTIC LLC
Additions
| Ticker | % Inc. |
|---|---|
| revolution medicines | 13.68 |
| chime | 10.68 |
Additions to existing portfolio by GENERAL ATLANTIC LLC
Reductions
| Ticker | % Reduced |
|---|---|
| webull | -99.29 |
| alignment healthcare | -45.78 |
| centessa pharmaceuticals | -36.81 |
| xp, inc | -11.05 |
GENERAL ATLANTIC LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| akero therapeutics | -272,250,000 |
| adagene | -7,526,860 |
| royalty pharma | -52,920,000 |
| alumis | -5,177,140 |
GENERAL ATLANTIC LLC got rid off the above stocks
Sector Distribution
GENERAL ATLANTIC, L.P. has about 63.2% of it's holdings in Others sector.
- Others
- Healthcare
- Technology
- Consumer Defensive
| Sector | % |
|---|---|
| Others | 63.2 |
| Healthcare | 25.4 |
| Technology | 9.6 |
| Consumer Defensive | 1.7 |
Market Cap. Distribution
GENERAL ATLANTIC, L.P. has about 7.8% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- SMALL-CAP
- MID-CAP
- LARGE-CAP
| Category | % |
|---|---|
| UNALLOCATED | 63.2 |
| SMALL-CAP | 14.5 |
| MID-CAP | 14.4 |
| LARGE-CAP | 7.8 |
Stocks belong to which Index?
About 31.4% of the stocks held by GENERAL ATLANTIC, L.P. either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 68.6 |
| RUSSELL 2000 | 31.4 |
GENERAL ATLANTIC LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of GENERAL ATLANTIC LLC
GENERAL ATLANTIC, L.P. has 13 stocks in it's portfolio. About 99% of the portfolio is in top 10 stocks. XP proved to be the most loss making stock for the portfolio. was the most profitable stock for GENERAL ATLANTIC, L.P. last quarter.
Last Reported on: 17 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ADAG | adagene | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AKRO | akero therapeutics | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALHC | alignment healthcare | 9.05 | 13,167,700 | 260,063,000 | reduced | -45.78 | ||
| ALKT | alkami | 9.63 | 11,991,500 | 276,643,000 | unchanged | 0.00 | ||
| CNTA | centessa pharmaceuticals | 5.33 | 6,117,720 | 153,004,000 | reduced | -36.81 | ||
| DLO | dlocal | 22.96 | 46,656,700 | 659,726,000 | unchanged | 0.00 | ||
| EWCZ | european wax center | 1.64 | 13,110,500 | 47,197,800 | unchanged | 0.00 | ||
| GROV | grove collaborative | 0.10 | 2,474,860 | 2,722,340 | unchanged | 0.00 | ||
| NRIX | nurix therapeutics | 3.23 | 4,897,160 | 92,899,100 | new | |||
| PHVS | pharvaris | 7.76 | 8,031,250 | 222,867,000 | unchanged | 0.00 | ||
| RPRX | royalty pharma | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| RSKD | riskified | 0.92 | 5,325,000 | 26,465,200 | unchanged | 0.00 | ||
| RVMD | revolution medicines | 7.80 | 2,812,930 | 224,050,000 | added | 13.68 | ||
| XP | xp, inc | 12.94 | 22,699,100 | 371,585,000 | reduced | -11.05 | ||
| chime | 18.63 | 21,259,700 | 535,106,000 | added | 10.68 | |||
| webull | 0.01 | 50,816 | 394,840 | reduced | -99.29 | |||
| alumis | 0.00 | 0.00 | 0.00 | sold off | -100 | |||